LABORATORY NEWS
-
BD Launches New Cell Analyzer Configurations To Bring Cutting-Edge Capabilities To Labs Of All Sizes
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the global commercial release of new configurations of cell analyzers featuring breakthrough spectral and real-time cell imaging technologies, enabling more labs in academia, pharma and biotech – across scales, needs and budgets – to advance discoveries in immunology, cancer immunotherapy and cell biology.
- Liebherr Expands Scientific And Healthcare Portfolio With New Generation Of Undercounter Appliances
- Perspectum And InHealth Announce National Diagnostics Partnership To Boost Oxford CDC Capacity And Widen Access To Advanced MRI Across The UK
- Siemens Healthineers Advances Coronary Artery Disease Management With Syngo.CT Coronary Cockpit Software
- A Molecular 'Reset Button' For Reading The Brain Through A Blood Test
ARCHIVED NEWSLETTER
- 11.25.25 -- Lunit & Labcorp To Advance AI-Powered Digital Pathology Research
- 11.11.25 -- Risk-Based Analytical Method Selection In Cleaning Validation Using ASTM International Standards
- 10.21.25 -- Automation In The Lab: Lessons From Successes And Setbacks
- 10.07.25 -- Unpacking Pfizer's Advanced Process Control Platform For Upstream Ops
- 09.23.25 -- Weight Of Evidence Assessments For Carcinogenicity Studies: An Overview